Peptides DB

Research-centric peptide and protocol reference hub

BPC-157

Research-centric overview

Peptide3 protocols

Body Protective Compound often discussed for soft-tissue repair, GI support, and inflammation modulation.

Community effect votes, structured logs, and side-effect summaries.

Effect profile (overview)

Aggregate AI baseline blended with community voting. Hover to inspect effect strengths per category.

Effect profile (AI + community): Healing & recovery 5.0/5 · Muscle & body comp 1.3/5 · Metabolic & appetite 1.0/5 · Neuro & mood 3.0/5 · Inflammation & immune 4.0/5 · Skin & aesthetics 2.0/5Healing 5.0Muscle 1.3Metabolic 1.0Neuro 3.0Sleep 0.0Inflammation 4.0Skin 2.0

Effect scores blend an AI baseline with community votes. Open the full chart to see sliders and vote on each category.

Research log summary heatmap

Compact view of how logs describe shifts in pain, sleep, and performance (−5 to +5). Treat this as qualitative, anonymous signal only.

Pain / discomfort+2/5
Sleep / recovery+2/5
Performance / output+1/5

Based on 10 anonymized research logs. Scroll down for full context and methodology.

Anonymous side-effect patterns

Rough heatmap of anonymous side-effect and positive-signal tags — a "most-mentioned" snapshot, not safety or efficacy advice.

48%improved healing
24%flushing
19%vivid dreams
5%nausea
3%anxiety

Research feed

Approved research items linked to this peptide.

Sort:Newest·Upvoted
Semantic Scholar search for BPC-157SemanticScholar
View source
Regeneration or Risk? A Narrative Review of BPC-157 for Musculoskeletal Healing.PubMed

Current reviews in musculoskeletal medicine · 2025

View source
BPC 157 Therapy: Targeting Angiogenesis and Nitric Oxide's Cytotoxic and Damaging Actions, but Maintaining, Promoting, or Recovering Their Essential Protective Functions. Comment on Józwiak et al. Multifunctionality and Possible Medical Application of the BPC 157 Peptide-Literature and Patent Review. Pharmaceuticals 2025, 18, 185.PubMed

Pharmaceuticals (Basel, Switzerland) · 2025

View source
Reply to Sikiric et al. BPC 157 Therapy: Targeting Angiogenesis and Nitric Oxide's Cytotoxic and Damaging Actions, but Maintaining, Promoting, or Recovering Their Essential Protective Functions. Comment on "Józwiak et al. Multifunctionality and Possible Medical Application of the BPC 157 Peptide-Literature and Patent Review. Pharmaceuticals 2025, 18, 185".PubMed

Pharmaceuticals (Basel, Switzerland) · 2025

View source

External databases

Helpful external resources for additional structural, pharmacologic, and literature context. These are third-party databases; always cross-check details with primary research.

PubChem search: BPC-157PubChem compound page (BPC-157)PubMed searchGoogle Scholar searchSemantic Scholar search

Protocols

View all protocols
Tissue repair micro-cycle (BPC-157 + TB-500 + GHK-Cu)

Exploratory tissue repair protocol stacking BPC-157, TB-500, and GHK-Cu for soft-tissue and connective-tissue support.

Glow Stack

Klow Stack

Community notes

No public comments yet. Use the form below to submit research questions or observations for admin review.

Submitted comments are queued for admin moderation.

Community research logs (detail)

Showing the latest 5 logs out of 10.

Goal: general repair / longevity

Context: sedentary / light • 36-45

Duration ~4.0 weeks • ~5.0 doses/week

Δ scores
Pain +1Sleep +2Perf +0

Diffuse joint stiffness and sleep quality tracked. Also added walking and basic mobility work.

Goal: injury / tissue repair

Context: recreational • 26-35

Duration ~8.0 weeks • ~7.0 doses/week

Δ scores
Pain +3Sleep +1Perf +2

Knee tendon discomfort after heavy training block. Combined with progressive PT 3x/week and sleep/nutrition focus.

Goal: general repair / longevity

Context: sedentary / light • 36-45

Duration ~4.0 weeks • ~5.0 doses/week

Δ scores
Pain +1Sleep +2Perf +0

Diffuse joint stiffness and sleep quality tracked. Also added walking and basic mobility work.

Goal: injury / tissue repair

Context: recreational • 26-35

Duration ~8.0 weeks • ~7.0 doses/week

Δ scores
Pain +3Sleep +1Perf +2

Knee tendon discomfort after heavy training block. Combined with progressive PT 3x/week and sleep/nutrition focus.

Goal: general repair / longevity

Context: sedentary / light • 36-45

Duration ~4.0 weeks • ~5.0 doses/week

Δ scores
Pain +1Sleep +2Perf +0

Diffuse joint stiffness and sleep quality tracked. Also added walking and basic mobility work.

How to read these logs

Each entry is a single, anonymized “n=1” summary with relative change sliders from −5 to +5. Higher positive values indicate perceived improvement; negative values indicate perceived worsening.

Context (training level, age band, duration, and dosing frequency) is shown so you can quickly skim for patterns or outliers. Treat this as qualitative signal layered on top of study data, not as a substitute for controlled trials.

Anonymous side-effect reporting (detail)

This section describes how anonymous side-effect reports are aggregated into the heatmap above. Reports are anonymous and unverified, and should be read alongside primary safety data.

Use the "Report side effects" button to open a focused popup form. Please keep descriptions neutral and avoid medical language; think in terms of "nausea", "flushing", "vivid dreams", etc.

Quick tone breakdown of submitted side-effect tags:

PositiveNegativeNeutral / mixed

Top reported tags so far (color reflects tone):

48%improved healing
24%flushing
19%vivid dreams

Questions & answers

Ask focused, research-style questions; answers can link to studies or protocols.

No questions yet. You can ask something focused about mechanisms, study design, or protocol choices below.